Title:
ANTIBODY MOLECULES TO C5AR1 AND USES THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/146320
Kind Code:
A8
Abstract:
Antibody molecules that specifically bind to C5aRl are disclosed. The antibody molecules can be used to treat, prevent, and/or diagnose disorders, such as ANCA-vasculitis.
More Like This:
| WO/2019/057100 | NOVEL ANTI-CD19 ANTIBODIES |
| JPH11506341 | [Title of Invention] G protein receptor HTNAD29 |
| JP2004518630 | New tumor-related markers |
Inventors:
VISWANATHAN KARTHIK (US)
BOOTH BRIAN (US)
RAMAKRISHNAN BOOPATHY (US)
WOLLACOTT ANDREW (US)
BABCOCK GREGORY (US)
SHRIVER ZACHARY (US)
BOOTH BRIAN (US)
RAMAKRISHNAN BOOPATHY (US)
WOLLACOTT ANDREW (US)
BABCOCK GREGORY (US)
SHRIVER ZACHARY (US)
Application Number:
PCT/US2021/013284
Publication Date:
July 28, 2022
Filing Date:
January 13, 2021
Export Citation:
Assignee:
VISTERRA INC (US)
International Classes:
C07K16/28; A61K39/395; A61P35/00; A61P37/00; C07K16/46
Attorney, Agent or Firm:
KIM, Sang-A (US)
Download PDF:
Previous Patent: TAILORED CONTACT PLAN GENERATION
Next Patent: METHODS OF MAKING POLYTETRAFLUOROETHYLENE/POLYMER COMPOSITES AND USES THEREOF
Next Patent: METHODS OF MAKING POLYTETRAFLUOROETHYLENE/POLYMER COMPOSITES AND USES THEREOF